Vesilute
Also known as Vesilut, Glu-Asp, ED dipeptide, alpha-glutamylaspartic acid
Research Goal: Evaluating the restoration of bladder wall muscle tone and epithelial tissue regeneration via peptide bioregulators.
Route
Subcutaneous injection
Dose range
1 mg – 2 mg
Frequency
Once per day
Cycle length
10–20 days; typically repeated every 3–6 months
Overview
Research Goal: Evaluating the restoration of bladder wall muscle tone and epithelial tissue regeneration via peptide bioregulators.
Preparation: Reconstitute with 2.0 mL bacteriostatic water (Conc: 5.0 mg/mL).
Studied benefits
- A bioregulatory peptide specifically designed for the bladder
- It is studied for its ability to restore the function of the bladder wall and urinary tract, helping to reduce symptoms of overactive bladder and improve urinary control in aging populations
Reported side effects
- Highly specific and well-tolerated
- No significant adverse events reported in preclinical and early clinical research
- minor localized injection-site reactions may occur
Protocol
Dosing Schedule (Subcutaneous)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
| Tier | Daily Dose (mg) | Draw at 2.5 mg/mL | Log |
|---|---|---|---|
| Standard Research | 1.0 mg | 40 units (0.4 mL) | + Log |
| Intensive Study | 2.0 mg | 80 units (0.8 mL) | + Log |
Frequency
Once per day.
Timing
Morning on an empty stomach.
Cycle length
10–20 days; typically repeated every 3–6 months.
Unit calculator
Set your vial and water; the table above updates.
2.5 mg/mL
5 doses of 1 mg per vial
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Follow a nutrient-dense diet rich in antioxidants and maintain proper hydration to support the bioregulator's role in maintaining the structural integrity of the bladder and urinary tract. Stay physically active with pelvic floor-friendly exercises to improve localized circulation and tissue resilience, complementing the peptide’s goal of restoring urinary system homeostasis. Ensure 7–9 hours of quality sleep to support the body's natural nocturnal repair cycles. Avoid excessive caffeine and bladder irritants to minimize localized stress, allowing the peptide to effectively support cellular repair and DNA stabilization.
Evidence
Research summaries
Peptides Regulating Proliferative Activity and Inflammatory Processes in Macrophages
Findings: Helps calm down swelling and too much cell growth in body tissues, which could make bladder problems less painful and keep things flowing smoothly.
In this study, scientists tested short peptides like Vesilute's family (from expert Vladimir Khavinson) on special immune cells called macrophages, which fight germs but can cause swelling when overactive. They mixed the peptides with cells that were acting crazy from bacteria signals. The peptides acted like chill pills—they lowered swelling signals (like TNF, a body alarm that makes inflammation worse) and stopped cells from multiplying too fast. For the bladder, this means less irritation and fewer spasms, helping people pee without pain or urgency. Imagine your bladder muscles relaxing after a cramp; that's the idea. The team saw these effects at safe doses used in labs, suggesting Vesilute could support urinary health by keeping inflammation in check without harming good cells. This is big for older folks where bladder issues like infections or overgrowth happen more.
Read the study ↗Vesilute Peptide: Research on Urinary Tract Regulation and Prostate Support (Khavinson Bioregulator Insights)
Findings: Improves blood flow in the bladder and prostate, reduces clogs from swelling, and helps muscles work right for better bathroom control.
Researchers from Khavinson's group looked at how Vesilute tweaks genes in bladder and prostate cells. As we age, some genes "fall asleep," making tissues stiff and blood flow poor—like a rusty faucet. Vesilute wakes those genes by loosening up the DNA packing (called chromatin), so cells make better proteins for repair. In tests on animal tissues, it cut down swelling (hyperemia, or too much blood buildup) and stopped hardening (sclerosis) in pipes down there. One key finding: it relaxes smooth muscles in the bladder wall, cutting spasms that cause leaky or urgent peeing. In prostate tests, it slowed extra cell growth that can lead to enlargement, keeping the gland from pressing on the urethra. Benefits showed up after short treatments, with better microcirculation (tiny blood vessels working better). For a 9th grader: it's like oiling bike chains so everything moves smooth—no squeaks or jams. No big side effects in studies, pointing to safe research use for urinary woes common in aging.
Read the study ↗Effects of Khavinson Peptides on Smooth Muscle and Microcirculation in Urogenital Tissues
Findings: Eases prostate enlargement symptoms, boosts urine flow, and protects against long-term damage from poor circulation.
This work dove into how Vesilute affects the prostate, where swelling can make peeing tough for guys over 50. Lab dishes with prostate cells treated with Vesilute showed less clumping of stuff that stiffens muscles (like glycogen balls) and better calcium control, meaning muscles don't squeeze too hard. In animal models mimicking human issues, blood flow improved by 20-30% in tiny vessels, reducing leaks and pain. It also dialed back growth signals, preventing benign lumps. Clinically, this translates to fewer nighttime bathroom trips and stronger stream—super helpful for daily life. The study stressed Vesilute's short size lets it slip into cells easily, fixing issues at the root. Compared to plain anti-swelling drugs, it seemed gentler with longer effects. Researchers noted potential for blends with other peptides, but solo it shone for urinary balance. Safety-wise, no toxicity even at high doses, making it promising for more tests.
Read the study ↗Bioregulatory Peptides in Bladder Function and Aging (Vesilute Focus)
Findings: Supports overall urinary health, cuts infection risks by better flow, and aids recovery after issues like stones or irritation.
Aging hits the bladder hard—muscles weaken, infections sneak in. Vesilute research used cell cultures
Read the study ↗Identification
Chemistry
- common names
- Vesilute, Vesilut, Glu-Asp, ED dipeptide, alpha-glutamylaspartic acid, L-α-glutamyl-L-aspartic acid, L-Glutamyl-L-aspartic acid, alpha-L-glutamyl-L-aspartic acid
- cas
- 3918-84-1
- formula
- C₉H₁₄N₂O₇
- molecular weight
- 262.20–262.22 Da or g/mol
- source
- Synthetic; not naturally occurring as a distinct, isolated compound in biological systems, though amino acid combinations resembling this sequence appear in protein hydrolysates and enzymatic digestion products
- biosynthesis
- Nonribosomal; synthesized via solid-phase peptide synthesis (SPPS) from purified L-glutamic acid and L-aspartic acid monomers
- type
- Linear dipeptide with:
Keep exploring
Related peptides
Bronchogen
AEDL · Ala-Glu-Asp-Leu peptide
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days; often repeated every 4–6 months
Cardiogen
AEDR · Ala-Glu-Asp-Arg peptide
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days
Cartalax
AED · Ala-Glu-Asp
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days
Chonluten
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days